| Subscribe To Our Free Newsletter |
Aurobindo slips 6% in a week after arm receives EIR from USFDA
In the past six months, Aurobindo has underperformed the market by falling 31 per cent, as compared to a marginal 0.07 per cent decline in the S&P BSE Sensex.
